InvestSMART

Noxopharm Limited (ASX: NOX) - Announcements

Current share price for NOX : $0.080 0.003 (3.61%)+

ASX company news and announcements for Noxopharm Limited (NOX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Noxopharm Limited (NOX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Noxopharm Limited (NOX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Noxopharm Limited (NOX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$25 Peer-Reviewed Publication Strengthens Case For Veyonda 11 Aug 2020 9:18AM $0.355 $0.080 fallen by 77.46%
$25 Noxopharm Extraordinary General Meeting Reminder 6 Aug 2020 9:05AM $0.320 $0.080 fallen by 75%
$25 Noxopharm 2020 June quarter Appendix 4C & Activities Report 29 Jul 2020 8:47AM $0.325 $0.080 fallen by 75.38%
$25 Change of Director's Interest Notice - FB 24 Jul 2020 6:36PM $0.335 $0.080 fallen by 76.12%
$25 Notice of Contravention of Listing Rule 10.11 24 Jul 2020 6:35PM $0.335 $0.080 fallen by 76.12%
$25 Noxopharm Discusses Converting Cold to Hot Cancer Tumours 23 Jul 2020 2:01PM $0.350 $0.080 fallen by 77.14%
$25 Receipt of cash payment for collateral shares 22 Jul 2020 9:23AM $0.365 $0.080 fallen by 78.08%
$25 Data Shows Idronoxil Holds Key to Problem of COLD Cancers 20 Jul 2020 9:02AM $0.330 $0.080 fallen by 75.76%
$25 Noxopharm July 2020 Newsletter Released 14 Jul 2020 11:02AM $0.305 $0.080 fallen by 73.77%
$25 Letter to Shareholders - Extraordinary General Meeting 14 Jul 2020 8:25AM $0.295 $0.080 fallen by 72.88%
$25 Notice of Extraordinary General Meeting/Proxy Form 14 Jul 2020 8:22AM $0.295 $0.080 fallen by 72.88%
$25 Corporate Presentation for the Reach Markets Virtual Event 8 Jul 2020 8:57AM $0.215 $0.080 fallen by 62.79%
$25 Ceasing to be a substantial holder 3 Jul 2020 4:23PM $0.200 $0.080 fallen by 60%
$25 Change of Director's Interest Notice - FB 29 Jun 2020 4:38PM $0.175 $0.080 fallen by 54.29%
$25 Change in substantial holding - amended 22 Jun 2020 4:39PM $0.195 $0.080 fallen by 58.97%
$25 Change in substantial holding 22 Jun 2020 3:54PM $0.200 $0.080 fallen by 60%
$25 Noxopharm Chair Letter to Shareholders 22 Jun 2020 9:05AM $0.205 $0.080 fallen by 60.98%
$25 COVID-19 Trial Program to Commence in Europe 19 Jun 2020 9:30AM $0.190 $0.080 fallen by 57.89%
$25 Change in substantial holding 18 Jun 2020 9:03AM $0.190 $0.080 fallen by 57.89%
$25 Change in substantial holding 18 Jun 2020 9:02AM $0.190 $0.080 fallen by 57.89%
$25 Change of Director's Interest Notice - BP 18 Jun 2020 8:59AM $0.190 $0.080 fallen by 57.89%
$25 Change of Director's Interest Notice - FB 18 Jun 2020 8:59AM $0.190 $0.080 fallen by 57.89%
$25 Change of Director's Interest Notice - PM 18 Jun 2020 8:59AM $0.190 $0.080 fallen by 57.89%
$25 Change of Director's Interest Notice - GK 18 Jun 2020 8:59AM $0.190 $0.080 fallen by 57.89%
$25 Appendix 2A - shares 18 Jun 2020 8:53AM $0.190 $0.080 fallen by 57.89%

376 - 400 of 794 results

Page 16 of 32

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.